nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.105	0.282	CbGbCtD
Saxagliptin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0711	0.19	CbGbCtD
Saxagliptin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0678	0.182	CbGbCtD
Saxagliptin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0604	0.162	CbGbCtD
Saxagliptin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0355	0.0949	CbGbCtD
Saxagliptin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0335	0.0896	CbGbCtD
Saxagliptin—Pancreatitis acute—Roflumilast—chronic obstructive pulmonary disease	0.0203	0.0427	CcSEcCtD
Saxagliptin—DPP8—bronchus—chronic obstructive pulmonary disease	0.0149	0.128	CbGeAlD
Saxagliptin—DPP8—smooth muscle tissue—chronic obstructive pulmonary disease	0.0146	0.126	CbGeAlD
Saxagliptin—DPP8—trachea—chronic obstructive pulmonary disease	0.0134	0.115	CbGeAlD
Saxagliptin—DPP9—lung—chronic obstructive pulmonary disease	0.0106	0.0909	CbGeAlD
Saxagliptin—Tuberculosis—Prednisone—chronic obstructive pulmonary disease	0.0102	0.0215	CcSEcCtD
Saxagliptin—DPP8—lung—chronic obstructive pulmonary disease	0.00964	0.0828	CbGeAlD
Saxagliptin—SLCO4C1—trachea—chronic obstructive pulmonary disease	0.00849	0.0729	CbGeAlD
Saxagliptin—DPP4—respiratory system—chronic obstructive pulmonary disease	0.00763	0.0655	CbGeAlD
Saxagliptin—DPP4—connective tissue—chronic obstructive pulmonary disease	0.00672	0.0577	CbGeAlD
Saxagliptin—DPP4—smooth muscle tissue—chronic obstructive pulmonary disease	0.00614	0.0527	CbGeAlD
Saxagliptin—SLCO4C1—lung—chronic obstructive pulmonary disease	0.0061	0.0524	CbGeAlD
Saxagliptin—Gastritis—Roflumilast—chronic obstructive pulmonary disease	0.00601	0.0127	CcSEcCtD
Saxagliptin—Infestation—Roflumilast—chronic obstructive pulmonary disease	0.00523	0.011	CcSEcCtD
Saxagliptin—Infestation NOS—Roflumilast—chronic obstructive pulmonary disease	0.00523	0.011	CcSEcCtD
Saxagliptin—Urinary tract infection—Roflumilast—chronic obstructive pulmonary disease	0.00509	0.0107	CcSEcCtD
Saxagliptin—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.00491	0.0103	CcSEcCtD
Saxagliptin—Opportunistic infection—Prednisone—chronic obstructive pulmonary disease	0.00464	0.00977	CcSEcCtD
Saxagliptin—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00424	0.00893	CcSEcCtD
Saxagliptin—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00409	0.00861	CcSEcCtD
Saxagliptin—DPP4—lung—chronic obstructive pulmonary disease	0.00405	0.0348	CbGeAlD
Saxagliptin—Pancreatitis acute—Prednisone—chronic obstructive pulmonary disease	0.00405	0.00852	CcSEcCtD
Saxagliptin—Gastroenteritis—Formoterol—chronic obstructive pulmonary disease	0.00389	0.00819	CcSEcCtD
Saxagliptin—Gastroenteritis—Arformoterol—chronic obstructive pulmonary disease	0.00389	0.00819	CcSEcCtD
Saxagliptin—Gastroenteritis—Montelukast—chronic obstructive pulmonary disease	0.00381	0.00802	CcSEcCtD
Saxagliptin—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00374	0.00787	CcSEcCtD
Saxagliptin—Gastroenteritis—Salbutamol—chronic obstructive pulmonary disease	0.00367	0.00773	CcSEcCtD
Saxagliptin—Lymphopenia—Prednisone—chronic obstructive pulmonary disease	0.00365	0.00769	CcSEcCtD
Saxagliptin—ABCC1—bronchus—chronic obstructive pulmonary disease	0.00355	0.0305	CbGeAlD
Saxagliptin—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00353	0.00744	CcSEcCtD
Saxagliptin—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00353	0.00744	CcSEcCtD
Saxagliptin—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00348	0.00733	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00346	0.00728	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00343	0.00722	CcSEcCtD
Saxagliptin—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00333	0.00702	CcSEcCtD
Saxagliptin—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00332	0.00698	CcSEcCtD
Saxagliptin—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.00332	0.0285	CbGeAlD
Saxagliptin—Hypertriglyceridaemia—Prednisone—chronic obstructive pulmonary disease	0.00325	0.00685	CcSEcCtD
Saxagliptin—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00324	0.00683	CcSEcCtD
Saxagliptin—Multiple fractures—Prednisone—chronic obstructive pulmonary disease	0.00321	0.00677	CcSEcCtD
Saxagliptin—Fracture—Prednisone—chronic obstructive pulmonary disease	0.00321	0.00677	CcSEcCtD
Saxagliptin—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.0032	0.00674	CcSEcCtD
Saxagliptin—ABCC1—trachea—chronic obstructive pulmonary disease	0.00319	0.0274	CbGeAlD
Saxagliptin—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.00309	0.0065	CcSEcCtD
Saxagliptin—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00308	0.00649	CcSEcCtD
Saxagliptin—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00308	0.00649	CcSEcCtD
Saxagliptin—Gastritis—Formoterol—chronic obstructive pulmonary disease	0.00305	0.00642	CcSEcCtD
Saxagliptin—Gastritis—Arformoterol—chronic obstructive pulmonary disease	0.00305	0.00642	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00304	0.0064	CcSEcCtD
Saxagliptin—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00302	0.00636	CcSEcCtD
Saxagliptin—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00294	0.00619	CcSEcCtD
Saxagliptin—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00291	0.00613	CcSEcCtD
Saxagliptin—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00291	0.00613	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00288	0.00607	CcSEcCtD
Saxagliptin—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00288	0.00606	CcSEcCtD
Saxagliptin—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.00286	0.00602	CcSEcCtD
Saxagliptin—Blood triglycerides increased—Prednisone—chronic obstructive pulmonary disease	0.00285	0.006	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00277	0.00583	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.00277	0.00583	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00273	0.00575	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.00271	0.00571	CcSEcCtD
Saxagliptin—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00267	0.00562	CcSEcCtD
Saxagliptin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00265	0.00558	CcSEcCtD
Saxagliptin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00264	0.00556	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00261	0.0055	CcSEcCtD
Saxagliptin—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.0026	0.00548	CcSEcCtD
Saxagliptin—Infestation—Montelukast—chronic obstructive pulmonary disease	0.0026	0.00548	CcSEcCtD
Saxagliptin—SLCO4C1—Transport of organic anions—ALB—chronic obstructive pulmonary disease	0.0026	0.074	CbGpPWpGaD
Saxagliptin—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00258	0.00544	CcSEcCtD
Saxagliptin—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.00258	0.00544	CcSEcCtD
Saxagliptin—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00257	0.00542	CcSEcCtD
Saxagliptin—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00249	0.00525	CcSEcCtD
Saxagliptin—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00249	0.00525	CcSEcCtD
Saxagliptin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00246	0.00518	CcSEcCtD
Saxagliptin—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.00244	0.00514	CcSEcCtD
Saxagliptin—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00244	0.00513	CcSEcCtD
Saxagliptin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00239	0.00504	CcSEcCtD
Saxagliptin—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00235	0.00495	CcSEcCtD
Saxagliptin—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00235	0.00495	CcSEcCtD
Saxagliptin—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00235	0.00495	CcSEcCtD
Saxagliptin—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00235	0.00495	CcSEcCtD
Saxagliptin—ABCC1—lung—chronic obstructive pulmonary disease	0.00229	0.0197	CbGeAlD
Saxagliptin—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00223	0.00469	CcSEcCtD
Saxagliptin—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00221	0.00466	CcSEcCtD
Saxagliptin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00221	0.00465	CcSEcCtD
Saxagliptin—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00219	0.00461	CcSEcCtD
Saxagliptin—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00219	0.00461	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00217	0.00458	CcSEcCtD
Saxagliptin—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00215	0.00453	CcSEcCtD
Saxagliptin—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00215	0.00453	CcSEcCtD
Saxagliptin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00212	0.00447	CcSEcCtD
Saxagliptin—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00211	0.00444	CcSEcCtD
Saxagliptin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0021	0.00443	CcSEcCtD
Saxagliptin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.0021	0.00443	CcSEcCtD
Saxagliptin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00209	0.0044	CcSEcCtD
Saxagliptin—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00208	0.00439	CcSEcCtD
Saxagliptin—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00208	0.00437	CcSEcCtD
Saxagliptin—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00208	0.00437	CcSEcCtD
Saxagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—LEP—chronic obstructive pulmonary disease	0.00206	0.0585	CbGpPWpGaD
Saxagliptin—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00204	0.00429	CcSEcCtD
Saxagliptin—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00203	0.00428	CcSEcCtD
Saxagliptin—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00203	0.0577	CbGpPWpGaD
Saxagliptin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00198	0.00417	CcSEcCtD
Saxagliptin—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.00413	CcSEcCtD
Saxagliptin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00196	0.00413	CcSEcCtD
Saxagliptin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00407	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00191	0.00403	CcSEcCtD
Saxagliptin—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00399	CcSEcCtD
Saxagliptin—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00399	CcSEcCtD
Saxagliptin—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00186	0.00391	CcSEcCtD
Saxagliptin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00185	0.00389	CcSEcCtD
Saxagliptin—DPP4—Incretin synthesis, secretion, and inactivation—LEP—chronic obstructive pulmonary disease	0.00183	0.0521	CbGpPWpGaD
Saxagliptin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00182	0.00383	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00181	0.00382	CcSEcCtD
Saxagliptin—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00377	CcSEcCtD
Saxagliptin—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00179	0.051	CbGpPWpGaD
Saxagliptin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.00372	CcSEcCtD
Saxagliptin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00372	CcSEcCtD
Saxagliptin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00372	CcSEcCtD
Saxagliptin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00372	CcSEcCtD
Saxagliptin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00372	CcSEcCtD
Saxagliptin—CYP3A5—lung—chronic obstructive pulmonary disease	0.00176	0.0151	CbGeAlD
Saxagliptin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00176	0.0037	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00175	0.0037	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00175	0.0037	CcSEcCtD
Saxagliptin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00364	CcSEcCtD
Saxagliptin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00364	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00172	0.00362	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00172	0.00361	CcSEcCtD
Saxagliptin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00169	0.00357	CcSEcCtD
Saxagliptin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00169	0.00357	CcSEcCtD
Saxagliptin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00168	0.00354	CcSEcCtD
Saxagliptin—Infection—Formoterol—chronic obstructive pulmonary disease	0.00168	0.00354	CcSEcCtD
Saxagliptin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00351	CcSEcCtD
Saxagliptin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00351	CcSEcCtD
Saxagliptin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00167	0.00351	CcSEcCtD
Saxagliptin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00166	0.00349	CcSEcCtD
Saxagliptin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00166	0.00349	CcSEcCtD
Saxagliptin—Infection—Montelukast—chronic obstructive pulmonary disease	0.00165	0.00347	CcSEcCtD
Saxagliptin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.00346	CcSEcCtD
Saxagliptin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00165	0.00346	CcSEcCtD
Saxagliptin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00164	0.00345	CcSEcCtD
Saxagliptin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00162	0.00342	CcSEcCtD
Saxagliptin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00161	0.00339	CcSEcCtD
Saxagliptin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.00337	CcSEcCtD
Saxagliptin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.00335	CcSEcCtD
Saxagliptin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00158	0.00333	CcSEcCtD
Saxagliptin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00157	0.00332	CcSEcCtD
Saxagliptin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00327	CcSEcCtD
Saxagliptin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00155	0.00326	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00154	0.00325	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.00325	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00318	CcSEcCtD
Saxagliptin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00314	CcSEcCtD
Saxagliptin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00314	CcSEcCtD
Saxagliptin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.00313	CcSEcCtD
Saxagliptin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00147	0.0031	CcSEcCtD
Saxagliptin—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00146	0.0417	CbGpPWpGaD
Saxagliptin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00308	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00308	CcSEcCtD
Saxagliptin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00308	CcSEcCtD
Saxagliptin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00308	CcSEcCtD
Saxagliptin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00308	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00307	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00302	CcSEcCtD
Saxagliptin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00301	CcSEcCtD
Saxagliptin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.00298	CcSEcCtD
Saxagliptin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00296	CcSEcCtD
Saxagliptin—Purpura—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00296	CcSEcCtD
Saxagliptin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00295	CcSEcCtD
Saxagliptin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00295	CcSEcCtD
Saxagliptin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00139	0.00294	CcSEcCtD
Saxagliptin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00139	0.00292	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00292	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00292	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00291	CcSEcCtD
Saxagliptin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.0029	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00286	CcSEcCtD
Saxagliptin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00283	CcSEcCtD
Saxagliptin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00283	CcSEcCtD
Saxagliptin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00282	CcSEcCtD
Saxagliptin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00282	CcSEcCtD
Saxagliptin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00281	CcSEcCtD
Saxagliptin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00279	CcSEcCtD
Saxagliptin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00278	CcSEcCtD
Saxagliptin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00132	0.00278	CcSEcCtD
Saxagliptin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00278	CcSEcCtD
Saxagliptin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00277	CcSEcCtD
Saxagliptin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00276	CcSEcCtD
Saxagliptin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00131	0.00276	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00275	CcSEcCtD
Saxagliptin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00268	CcSEcCtD
Saxagliptin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00266	CcSEcCtD
Saxagliptin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00263	CcSEcCtD
Saxagliptin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00263	CcSEcCtD
Saxagliptin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00263	CcSEcCtD
Saxagliptin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00257	CcSEcCtD
Saxagliptin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00256	CcSEcCtD
Saxagliptin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00256	CcSEcCtD
Saxagliptin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00252	CcSEcCtD
Saxagliptin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00252	CcSEcCtD
Saxagliptin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00251	CcSEcCtD
Saxagliptin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00248	CcSEcCtD
Saxagliptin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00247	CcSEcCtD
Saxagliptin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00242	CcSEcCtD
Saxagliptin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00242	CcSEcCtD
Saxagliptin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00238	CcSEcCtD
Saxagliptin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00236	CcSEcCtD
Saxagliptin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00236	CcSEcCtD
Saxagliptin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00231	CcSEcCtD
Saxagliptin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00227	CcSEcCtD
Saxagliptin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00227	CcSEcCtD
Saxagliptin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00227	CcSEcCtD
Saxagliptin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00225	CcSEcCtD
Saxagliptin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00225	CcSEcCtD
Saxagliptin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00225	CcSEcCtD
Saxagliptin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00225	CcSEcCtD
Saxagliptin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00223	CcSEcCtD
Saxagliptin—Headache—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00223	CcSEcCtD
Saxagliptin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00223	CcSEcCtD
Saxagliptin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00222	CcSEcCtD
Saxagliptin—Rash—Montelukast—chronic obstructive pulmonary disease	0.00105	0.0022	CcSEcCtD
Saxagliptin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00105	0.0022	CcSEcCtD
Saxagliptin—Headache—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00219	CcSEcCtD
Saxagliptin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00216	CcSEcCtD
Saxagliptin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00214	CcSEcCtD
Saxagliptin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00212	CcSEcCtD
Saxagliptin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00212	CcSEcCtD
Saxagliptin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00212	CcSEcCtD
Saxagliptin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00212	CcSEcCtD
Saxagliptin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00211	CcSEcCtD
Saxagliptin—DPP4—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	0.000998	0.0284	CbGpPWpGaD
Saxagliptin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000985	0.00208	CcSEcCtD
Saxagliptin—SLCO4C1—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.000965	0.0275	CbGpPWpGaD
Saxagliptin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00095	0.002	CcSEcCtD
Saxagliptin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000917	0.00193	CcSEcCtD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000894	0.0254	CbGpPWpGaD
Saxagliptin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000847	0.00178	CcSEcCtD
Saxagliptin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000817	0.00172	CcSEcCtD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000796	0.0227	CbGpPWpGaD
Saxagliptin—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000746	0.00157	CcSEcCtD
Saxagliptin—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000743	0.0212	CbGpPWpGaD
Saxagliptin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000729	0.00153	CcSEcCtD
Saxagliptin—CYP3A5—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000719	0.0205	CbGpPWpGaD
Saxagliptin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000695	0.00146	CcSEcCtD
Saxagliptin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000695	0.00146	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000691	0.00145	CcSEcCtD
Saxagliptin—CYP3A5—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00069	0.0197	CbGpPWpGaD
Saxagliptin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000676	0.00142	CcSEcCtD
Saxagliptin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000667	0.0014	CcSEcCtD
Saxagliptin—CYP3A5—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000664	0.0189	CbGpPWpGaD
Saxagliptin—Infection—Prednisone—chronic obstructive pulmonary disease	0.000662	0.00139	CcSEcCtD
Saxagliptin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000647	0.00136	CcSEcCtD
Saxagliptin—DPP4—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	0.00062	0.0177	CbGpPWpGaD
Saxagliptin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000607	0.00128	CcSEcCtD
Saxagliptin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000607	0.00128	CcSEcCtD
Saxagliptin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000587	0.00124	CcSEcCtD
Saxagliptin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000578	0.00122	CcSEcCtD
Saxagliptin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000578	0.00122	CcSEcCtD
Saxagliptin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000575	0.00121	CcSEcCtD
Saxagliptin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000575	0.00121	CcSEcCtD
Saxagliptin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00057	0.0162	CbGpPWpGaD
Saxagliptin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000545	0.00115	CcSEcCtD
Saxagliptin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000545	0.00115	CcSEcCtD
Saxagliptin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00053	0.00112	CcSEcCtD
Saxagliptin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000527	0.00111	CcSEcCtD
Saxagliptin—ABCC1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000526	0.015	CbGpPWpGaD
Saxagliptin—CYP3A5—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000502	0.0143	CbGpPWpGaD
Saxagliptin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000491	0.00103	CcSEcCtD
Saxagliptin—CYP3A5—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000482	0.0137	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000481	0.0137	CbGpPWpGaD
Saxagliptin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000478	0.00101	CcSEcCtD
Saxagliptin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000472	0.000993	CcSEcCtD
Saxagliptin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000442	0.0126	CbGpPWpGaD
Saxagliptin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000441	0.000928	CcSEcCtD
Saxagliptin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000424	0.000892	CcSEcCtD
Saxagliptin—Rash—Prednisone—chronic obstructive pulmonary disease	0.00042	0.000885	CcSEcCtD
Saxagliptin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00042	0.000884	CcSEcCtD
Saxagliptin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000418	0.000879	CcSEcCtD
Saxagliptin—DPP4—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000409	0.0116	CbGpPWpGaD
Saxagliptin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000396	0.000834	CcSEcCtD
Saxagliptin—ABCC1—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000388	0.0111	CbGpPWpGaD
Saxagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000384	0.0109	CbGpPWpGaD
Saxagliptin—ABCC1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000382	0.0109	CbGpPWpGaD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000375	0.0107	CbGpPWpGaD
Saxagliptin—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000349	0.00994	CbGpPWpGaD
Saxagliptin—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000334	0.00952	CbGpPWpGaD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000334	0.00952	CbGpPWpGaD
Saxagliptin—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000321	0.00914	CbGpPWpGaD
Saxagliptin—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000309	0.00879	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.0003	0.00854	CbGpPWpGaD
Saxagliptin—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000293	0.00835	CbGpPWpGaD
Saxagliptin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000287	0.00816	CbGpPWpGaD
Saxagliptin—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000283	0.00806	CbGpPWpGaD
Saxagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000279	0.00794	CbGpPWpGaD
Saxagliptin—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000268	0.00762	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000267	0.00761	CbGpPWpGaD
Saxagliptin—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000254	0.00722	CbGpPWpGaD
Saxagliptin—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000233	0.00664	CbGpPWpGaD
Saxagliptin—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000232	0.00662	CbGpPWpGaD
Saxagliptin—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000224	0.00639	CbGpPWpGaD
Saxagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00021	0.00598	CbGpPWpGaD
Saxagliptin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000208	0.00593	CbGpPWpGaD
Saxagliptin—SLCO4C1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000207	0.0059	CbGpPWpGaD
Saxagliptin—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000206	0.00585	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000188	0.00537	CbGpPWpGaD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000175	0.00499	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000169	0.00482	CbGpPWpGaD
Saxagliptin—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000169	0.00481	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000166	0.00472	CbGpPWpGaD
Saxagliptin—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000165	0.00469	CbGpPWpGaD
Saxagliptin—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000149	0.00423	CbGpPWpGaD
Saxagliptin—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000147	0.00418	CbGpPWpGaD
Saxagliptin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000136	0.00388	CbGpPWpGaD
Saxagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.00379	CbGpPWpGaD
Saxagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.00374	CbGpPWpGaD
Saxagliptin—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00352	CbGpPWpGaD
Saxagliptin—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.00347	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000121	0.00344	CbGpPWpGaD
Saxagliptin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00012	0.00341	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000117	0.00333	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000114	0.00326	CbGpPWpGaD
Saxagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.00308	CbGpPWpGaD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000105	0.003	CbGpPWpGaD
Saxagliptin—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000103	0.00293	CbGpPWpGaD
Saxagliptin—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000102	0.00289	CbGpPWpGaD
Saxagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.68e-05	0.00276	CbGpPWpGaD
Saxagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.56e-05	0.00272	CbGpPWpGaD
Saxagliptin—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.46e-05	0.00269	CbGpPWpGaD
Saxagliptin—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.33e-05	0.00266	CbGpPWpGaD
Saxagliptin—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.97e-05	0.00255	CbGpPWpGaD
Saxagliptin—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.85e-05	0.00252	CbGpPWpGaD
Saxagliptin—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	8.7e-05	0.00248	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.16e-05	0.00232	CbGpPWpGaD
Saxagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.85e-05	0.00224	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	7.78e-05	0.00222	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.58e-05	0.00216	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.52e-05	0.00214	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GC—chronic obstructive pulmonary disease	7.38e-05	0.0021	CbGpPWpGaD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.36e-05	0.0021	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	7.22e-05	0.00205	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.91e-05	0.00197	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.86e-05	0.00195	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.83e-05	0.00194	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.88e-05	0.00167	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.74e-05	0.00163	CbGpPWpGaD
Saxagliptin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.66e-05	0.00161	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.46e-05	0.00156	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.79e-05	0.00136	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.78e-05	0.00136	CbGpPWpGaD
Saxagliptin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.72e-05	0.00134	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	4.65e-05	0.00132	CbGpPWpGaD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.42e-05	0.00126	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.4e-05	0.00125	CbGpPWpGaD
Saxagliptin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.34e-05	0.00124	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.32e-05	0.00123	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.17e-05	0.00119	CbGpPWpGaD
Saxagliptin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.11e-05	0.00117	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	4.04e-05	0.00115	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.03e-05	0.00115	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.98e-05	0.00113	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—KL—chronic obstructive pulmonary disease	3.76e-05	0.00107	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.71e-05	0.00106	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.63e-05	0.00103	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.53e-05	0.00101	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.36e-05	0.000955	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.35e-05	0.000953	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	2.82e-05	0.000802	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.79e-05	0.000795	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.75e-05	0.000784	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.57e-05	0.000731	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.54e-05	0.000723	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.51e-05	0.000715	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.43e-05	0.000693	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	2.35e-05	0.000669	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.29e-05	0.000652	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.22e-05	0.000633	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.16e-05	0.000616	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.11e-05	0.000601	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.01e-05	0.000572	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.98e-05	0.000563	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	1.89e-05	0.000538	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.76e-05	0.000501	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.74e-05	0.000494	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	1.65e-05	0.000471	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.62e-05	0.000461	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.58e-05	0.00045	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.53e-05	0.000437	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	1.25e-05	0.000356	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	1.22e-05	0.000349	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.18e-05	0.000336	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.17e-05	0.000332	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.07e-05	0.000303	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.04e-05	0.000297	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	9.98e-06	0.000284	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.82e-06	0.000279	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	9.41e-06	0.000268	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.19e-06	0.000233	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.07e-06	0.00023	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.52e-06	0.000214	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.13e-06	0.000203	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.85e-06	0.000138	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.64e-06	0.000132	CbGpPWpGaD
